6505-00-560-7743 ( GARAMYCIN , NDC00085-0069-06 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-00-560-7743 | 6505 | 005607743 | GENTAMICIN SULFATE INJECTION,USP | 3057 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CSGS | ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 40.000 MILLIGRAMS GENTAMICIN EQUIVALENT |
| FEAT | SPECIAL FEATURES | NEEDLE SIZE 22 GAGE BY 1-1/4 IN.; DISPOSABLE |
| CQCT | PRIMARY CONTAINER TYPE | SYRINGE WITH NEEDLE |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| GARAMYCIN | 53300 | A | 1 | 5 | 4 | 75 | |
| NDC00085-0069-06 | 53300 | A | 2 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| GARAMYCIN | 53300 | SCHERING CORP | A | A |
| NDC00085-0069-06 | 53300 | SCHERING CORP | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 11/14/1 | P | 3004200060 | 3057 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DN | 9L----- | N | V | DISCONTINUED W/O REPLACEMENT | |
| VA | V |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | S9M | Y | 1 | EA | M | U | 9L----- | N | |
| VA | G36 | Y | A | EA | M | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|